Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the presence of BCR-ABL1 transcript as a result of reciprocal translocation between chromosome 9 and 22. The most common transcripts subtypes are e13a2 (b2a2) and e14a2 (b3a2). The prognostic impact of the type of BCR-A...

Descripción completa

Detalles Bibliográficos
Autores principales: Genthon, Alexis, Nicolini, Franck Emmanuel, Huguet, Françoise, Colin-Gil, Carole, Berger, Marc, Saugues, Sandrine, Janel, Alexandre, Hayette, Sandrine, Cohny-Makhoul, Pascale, Cadoux, Nadine, Cayuela, Jean-Michel, Campos, Lydia, Guyotat, Denis, Flandrin-Gresta, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335668/
https://www.ncbi.nlm.nih.gov/pubmed/32655840
http://dx.doi.org/10.18632/oncotarget.27652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335668/
https://www.ncbi.nlm.nih.gov/pubmed/32655840
http://dx.doi.org/10.18632/oncotarget.27652

Ejemplares similares